0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc DRC's Basic EPS Incl Extra Items:
We've identified the following companies as similar to GSK plc DRC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Basic EPS Incl Extra Items |
|---|---|---|
| Healthcare | SECTOR:HLTH.GB | -0.022 |
| Sandoz Group AG | LSE:0SAN | - |
| GSK plc DRC | NYSE:GSK | 0.79 |
| Genomma Lab Internacional SAB De CV | BMV:LABB | 2.18 |
| H Lundbeck L | LSE:0ND5 | 3.17 |
| AstraZeneca PLC | LSE:AZN | 3.63 |
| Sanofi L | LSE:0O59 | 4.44 |
| Novartis AG | LSE:0QLR | 5.37 |
| Merck KGaA | LSE:0O14 | 6.39 |
| Merck & Co Inc | LSE:0QAH | 6.76 |
| Roche Holding AG Participation | LSE:0QOK | 10.39 |
| Kyorin Holdings Inc | TSE:4569 | 66.96 |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Basic EPS Incl Extra Items in the financials category include:
Company's net earnings or losses from continuing operations adjusted for certain one-time items on a per basic share basis.
GSK reported basic eps of 0.79 for the latest twelve months ending December 31, 2024 on its income statement.
Basic EPS Incl Extra Items measures the amount of earnings per outstanding share of common stock for a company.
Basic Net Income = Net Income - Preferred Dividends
Basic EPS = Basic Net Income / Shares Outstanding
Basic EPS differs from Diluted EPS. Diluted EPS takes into account the impact of dilutive securities like stock options or convertible bonds that a company may have in its financing structure
The tables below summarises GSK’s basic eps over the last five years:
| Fiscal Year | Basic EPS |
|---|---|
| 2020-12-31 | 1.97 |
| 2021-12-31 | 1.48 |
| 2022-12-31 | 4.49 |
| 2023-12-31 | 1.55 |
| 2024-12-31 | 0.79 |
The tables below summarizes GSK’s basic eps over the last four quarters:
| Quarter Ending | Basic EPS |
|---|---|
| 2024-03-31 | 0.32 |
| 2024-06-30 | 0.36 |
| 2024-09-30 | -0.019 |
| 2024-12-31 | 0.13 |
The chart above depicts the distribution of basic eps incl extra items for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,357 had meaningful values. The average basic eps incl extra items of companies in the sector is -1.08 with a standard deviation of 3.69.
GSK plc DRC's Basic EPS Incl Extra Items of 0.79 ranks in the 89.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,455 |
| Included Constituents | 2,357 |
| Min | -33.87 |
| Max | 7.86 |
| Median | -0.10 |
| Mean | -1.08 |
| Standard Deviation | 3.69 |
You can find companies with similar basic eps incl extra items using this stock screener.